• LAST PRICE
    201.4825
  • TODAY'S CHANGE (%)
    Trending Up1.0125 (0.5051%)
  • Bid / Lots
    201.4200/ 3
  • Ask / Lots
    201.5100/ 8
  • Open / Previous Close
    200.4900 / 200.4700
  • Day Range
    Low 198.3500
    High 202.1025
  • 52 Week Range
    Low 135.8500
    High 207.3200
  • Volume
    1,732,458
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 200.47
TimeVolumeABBV
09:32 ET64638200.33
09:33 ET24465199.95
09:35 ET13195198.95
09:37 ET11502198.58
09:39 ET6813198.99
09:42 ET3578199.58
09:44 ET4761199.87
09:46 ET2774199.8
09:48 ET3436199.81
09:50 ET8561199.46
09:51 ET4579199.385
09:53 ET6156199.63
09:55 ET10245199.68
09:57 ET4500199.77
10:00 ET7183199.9907
10:02 ET26238199.57
10:04 ET5322199.85
10:06 ET8359199.75
10:08 ET14926199.9675
10:09 ET9338199.715
10:11 ET10752199.975
10:13 ET6984199.61
10:15 ET19980199.34
10:18 ET14541199.1
10:20 ET5840199.52
10:22 ET3745199.625
10:24 ET4160199.63
10:26 ET6388199.74
10:27 ET4832199.66
10:29 ET10826199.69
10:31 ET9257199.9102
10:33 ET5404199.935
10:36 ET5026200.23
10:38 ET22340200.265
10:40 ET9775200.48
10:42 ET20954200.5
10:44 ET10566200.555
10:45 ET8145200.39
10:47 ET13526200.41
10:49 ET5786200.35
10:51 ET10646200.27
10:54 ET5662200.22
10:56 ET9512200.2859
10:58 ET10709200.31
11:00 ET10847200.36
11:02 ET12151200.84
11:03 ET13275200.97
11:05 ET33721201.03
11:07 ET14030200.87
11:09 ET8998201.06
11:12 ET20662201.085
11:14 ET5261201.13
11:16 ET12635200.985
11:18 ET7368201.1113
11:20 ET6942201.05
11:21 ET41900201.16
11:23 ET5292200.9918
11:25 ET18909201.01
11:27 ET9224200.82
11:30 ET3471200.88
11:32 ET20789200.85
11:34 ET15880201.0925
11:36 ET11431201.18
11:38 ET11974201.18
11:39 ET5691201.215
11:41 ET5270201.345
11:43 ET11029201.23
11:45 ET11164201.22
11:48 ET4248201.26
11:50 ET4027201.3824
11:52 ET4310201.465
11:54 ET6615201.42
11:56 ET31382201.65
11:57 ET3000201.615
11:59 ET29182201.49
12:01 ET12760201.32
12:03 ET1814201.36
12:06 ET9467201.64
12:08 ET9549201.875
12:10 ET10659201.71
12:12 ET7197201.7992
12:14 ET4953201.925
12:15 ET25470201.845
12:17 ET7630201.95
12:19 ET5308201.9101
12:21 ET6552201.88
12:24 ET3151201.875
12:26 ET17841201.88
12:28 ET3254201.94
12:30 ET6825201.78
12:32 ET7563201.63
12:33 ET8315201.72
12:35 ET4706201.72
12:37 ET4476201.77
12:39 ET3974201.875
12:42 ET4219201.66
12:44 ET4141201.5571
12:46 ET11808201.37
12:48 ET7495201.48
12:50 ET11587201.6
12:51 ET7215201.475
12:53 ET24692201.525
12:55 ET17559201.545
12:57 ET4137201.54
01:00 ET5041201.54
01:02 ET9263201.48
01:04 ET4758201.57
01:06 ET6172201.565
01:08 ET22245201.47
01:09 ET2211201.4825
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesABBV
AbbVie Inc
354.1B
70.3x
-6.05%
United StatesMRK
Merck & Co Inc
258.2B
21.3x
-43.23%
United StatesNVS
Novartis AG
240.6B
19.1x
-5.59%
United StatesAZN
AstraZeneca PLC
221.3B
32.2x
+17.52%
United StatesRHHBY
Roche Holding AG
256.5B
20.4x
+3.28%
United StatesJNJ
Johnson & Johnson
381.0B
26.0x
-1.47%
As of 2024-11-05

Company Information

AbbVie Inc. is a diversified research-based biopharmaceutical company engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers a comprehensive product portfolio across Immunology, Oncology, Neuroscience, Eye Care, Aesthetics, and Other Specialties. Immunology includes Rheumatology, Dermatology, and Gastroenterology. Oncology includes Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Diffuse large B-cell lymphoma, and others. Neuroscience includes Parkinson's disease, Migraine, Movement Disorders, Psychiatric Disorders, and Alzheimer’s disease. Eye Care includes Chronic Dry Eye Disease, Glaucoma, Age-Related Retinal Diseases, and Refractive Disorders. Aesthetics includes Botox Cosmetic, The Juvederm Collection of Fillers, and others. It offers NX-13 for the treatment of ulcerative colitis (UC) and Crohn's disease (CD). It also offers CEL383 for the treatment of inflammatory bowel disease.

Contact Information

Headquarters
1 N Waukegan RdNORTH CHICAGO, IL, United States 60064
Phone
847-932-7900
Fax
302-655-5049

Executives

Executive Chairman of the Board
Richard Gonzalez
Chief Executive Officer, Director
Robert Michael
Chief Financial Officer, Executive Vice President
Scott Reents
Chief Human Resource Officer, Executive Vice President
Timothy Richmond
Executive Vice President - Research & Development, Chief Scientific Officer
Roopal Thakkar

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$354.1B
Revenue (TTM)
$55.5B
Shares Outstanding
1.8B
Dividend Yield
3.26%
Annual Dividend Rate
6.5600 USD
Ex-Dividend Date
01-15-25
Pay Date
02-14-25
Beta
0.60
EPS
$2.87
Book Value
$5.87
P/E Ratio
70.3x
Price/Sales (TTM)
6.4
Price/Cash Flow (TTM)
26.2x
Operating Margin
24.89%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.